{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 2917"}, "official-title": {"#tail": "\n\t", "#text": "To expand the program of priority review to encourage treatments for tropical diseases.  "}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20141112", "#text": "November 12, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Harkin", "@name-id": "S172"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Alexander", "@name-id": "S289"}, {"#tail": ", ", "#text": "Ms. Mikulski", "@name-id": "S182"}, {"#tail": ", ", "#text": "Mr. Enzi", "@name-id": "S254"}, {"#tail": ", ", "#text": "Mrs. Murray", "@name-id": "S229"}, {"#tail": ", ", "#text": "Mr. Burr", "@name-id": "S300"}, {"#tail": ", ", "#text": "Mr. Casey", "@name-id": "S309"}, {"#tail": ", ", "#text": "Mr. Isakson", "@name-id": "S305"}, {"#tail": ", ", "#text": "Mrs. Hagan", "@name-id": "S320"}, {"#tail": ", ", "#text": "Mr. Hatch", "@name-id": "S118"}, {"#tail": ", ", "#text": "Mr. Franken", "@name-id": "S332"}, {"#tail": ", ", "#text": "Mr. Roberts", "@name-id": "S260"}, {"#tail": ", ", "#text": "Mr. Bennet", "@name-id": "S330"}, {"#tail": ", ", "#text": "Mr. Kirk", "@name-id": "S339"}, {"#tail": ", ", "#text": "Mr. Whitehouse", "@name-id": "S316"}, {"#tail": ", ", "#text": "Mr. Scott", "@name-id": "S365"}, {"#tail": ", ", "#text": "Ms. Baldwin", "@name-id": "S354"}, {"#tail": ", ", "#text": "Mr. Murphy", "@name-id": "S364"}, {"#tail": ", ", "#text": "Ms. Warren", "@name-id": "S366"}, {"#tail": ", ", "#text": "Ms. Klobuchar", "@name-id": "S311"}, {"#tail": ", ", "#text": "Mr. Blumenthal", "@name-id": "S341"}, {"#tail": ", ", "#text": "Mr. Markey", "@name-id": "S369"}, {"#tail": ", ", "#text": "Mr. Brown", "@name-id": "S307"}, {"#tail": ", ", "#text": "Mr. Coburn", "@name-id": "S301"}, {"#tail": ", and ", "#text": "Ms. Collins", "@name-id": "S252"}, {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Durbin", "@name-id": "S253"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Adding Ebola to the FDA Priority Review Voucher Program Act", "@value": "Adding Ebola to the FDA Priority Review Voucher Program Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "S1"}, {"@section-type": "subsequent-section", "#tail": "\n  ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 524 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:524"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 360n", "@value": "usc/21/360n"}, "@parsable-cite": "usc/21/360n", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Priority review to encourage treatments for tropical diseases"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "in subsection (a)(3)\u2014"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "#text": "\n        ", "@id": "idE49BCCB76D8B4A9FAB3630A41EFE8199", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "by redesignating subparagraph (Q) as subparagraph (R);"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "idAA07FBC2ED85428E865A091CE17C5862", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "by inserting after subparagraph (P) the following:"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "; and"}, "#tail": "\n        ", "@id": "id10673255AEBC4BE3A7DF7D617AE81911", "@display-inline": "no-display-inline", "#text": "\n            ", "subparagraph": {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "Filoviruses."}, "enum": {"#tail": "\n              ", "#text": "(Q)"}, "@id": "id7F814DCACA9B46E993BAD77D0E40A7D4", "#text": "\n              "}}, "#text": "\n          ", "@id": "id16A78F9A04DB4C55AB10E3AC20548949"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": "regulation by"}, {"#tail": "; and", "#text": "order of"}], "#text": "in subparagraph (R), as so redesignated, by striking "}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "idA3718C1E988343D4952CCF46F5B64EAF", "#text": "\n          "}]}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "#text": "in subsection (b)\u2014"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "#text": "\n        ", "@id": "idE7874CA2ED7E49C9A4CED53DE1BDA117", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "quote": {"#tail": " after the period at the end; and", "#text": "There is no limit on the number of times a priority review voucher may be transferred before such\n\t\t\t voucher is used."}, "#text": "in paragraph (2), by adding "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "idCCD0528AE3A945F895A04B573AFCC0A4", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "365 days"}, {"#tail": ".", "#text": "90 days"}], "#text": "in paragraph (4), by striking "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "id5AF8FF406045498DA9E2427B97DB741B", "#text": "\n          "}]}], "#text": "\n      ", "@id": "id0FB2205E53A34A4B85A62C8391E370CF"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-11-12"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2917 IS: Adding Ebola to the FDA Priority Review Voucher Program Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}